Resources from the same session
Introduction
Presenter: Christopher Booth
Session: How does real-world evidence inform decision making for new drug funding?
Resources:
Webcast
Real-world evidence and regulatory drug approval
Presenter: Christopher Booth
Session: How does real-world evidence inform decision making for new drug funding?
Resources:
Slides
Webcast
RWE: When should it be used by EMA?
Presenter: Francesco Pignatti
Session: How does real-world evidence inform decision making for new drug funding?
Resources:
Slides
Webcast
Challenges of collecting RWE: Limitations of administrative data sets, complex methodological issues, responsibility for collecting data
Presenter: Valery Lemmens
Session: How does real-world evidence inform decision making for new drug funding?
Resources:
Slides
Webcast